|
|
 |
REFAMETINIB |
923032-37-5 |
|
4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸3,5-二氯苄酯 |
1144035-53-9 |
|
FGFR抑制剂(NVP-BGJ398) |
872511-34-7 |
|
JTE-013 |
383150-41-2 |
|
(2S)-N1-[4-甲基-5-[2-(2,2,2-三氟-1,1-二甲基乙基)-4-吡啶基]-2-噻唑基]-1,2-吡咯烷二甲酰胺 |
1217486-61-7 |
|
米铂 |
141977-79-9 |
|
Filgotinib |
1206161-97-8 |
|
N-羟基-1-(4-甲氧基苄基)-1H-吲哚-6-甲酰胺 |
950762-95-5 |
|
GSK2636771 |
1372540-25-4 |
|
AUZ454或者K03861 |
853299-07-7 |
|
N/A |
442908-10-3 |
|
N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-A]吡啶-2-胺 |
1257704-57-6 |
|
依帕列净 |
864070-44-0 |
|
GDC0068,RG7440 |
1001264-89-6 |
|
6-(3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPIN-7-YLOXY)-N-METHYLNICOTINAMIDE |
720690-73-3 |
|
21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 
